GAMMA Investing LLC raised its stake in Exponent, Inc. (NASDAQ:EXPO – Free Report) by 8,065.9% in the 1st quarter, Holdings Channel.com reports. The institutional investor owned 33,072 shares of the business services provider’s stock after buying an additional 32,667 shares during the period. GAMMA Investing LLC’s holdings in Exponent were worth $2,681,000 at the end of the most recent quarter.
Other large investors also recently added to or reduced their stakes in the company. Raymond James Financial Inc. purchased a new stake in shares of Exponent in the 4th quarter worth approximately $55,131,000. Norges Bank purchased a new stake in shares of Exponent in the 4th quarter worth approximately $52,381,000. Resona Asset Management Co. Ltd. purchased a new stake in shares of Exponent in the 4th quarter worth approximately $38,538,000. BLI Banque de Luxembourg Investments purchased a new stake in shares of Exponent in the 4th quarter worth approximately $12,564,000. Finally, Barclays PLC lifted its position in shares of Exponent by 88.5% in the 4th quarter. Barclays PLC now owns 181,921 shares of the business services provider’s stock worth $16,209,000 after purchasing an additional 85,395 shares during the period. 92.37% of the stock is owned by hedge funds and other institutional investors.
Insider Transactions at Exponent
In related news, VP Joseph Rakow sold 1,573 shares of the stock in a transaction that occurred on Tuesday, May 27th. The shares were sold at an average price of $77.72, for a total transaction of $122,253.56. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, VP Bradley A. James sold 2,694 shares of the stock in a transaction that occurred on Tuesday, May 20th. The shares were sold at an average price of $79.52, for a total transaction of $214,226.88. The disclosure for this sale can be found here. In the last quarter, insiders sold 6,267 shares of company stock valued at $489,120. Company insiders own 2.10% of the company’s stock.
Exponent Stock Performance
Exponent (NASDAQ:EXPO – Get Free Report) last announced its quarterly earnings results on Thursday, May 1st. The business services provider reported $0.52 earnings per share for the quarter, topping the consensus estimate of $0.48 by $0.04. Exponent had a net margin of 19.52% and a return on equity of 27.27%. The firm had revenue of $137.44 million during the quarter, compared to analysts’ expectations of $134.63 million. During the same quarter in the prior year, the company earned $0.59 EPS. The company’s revenue was up .2% compared to the same quarter last year. Equities research analysts forecast that Exponent, Inc. will post 1.98 EPS for the current year.
Exponent Dividend Announcement
The firm also recently declared a quarterly dividend, which will be paid on Friday, June 20th. Stockholders of record on Friday, June 6th will be given a $0.30 dividend. The ex-dividend date is Friday, June 6th. This represents a $1.20 annualized dividend and a dividend yield of 1.59%. Exponent’s payout ratio is presently 58.54%.
Exponent Company Profile
Exponent, Inc, together with its subsidiaries, operates as a science and engineering consulting company in the United States and internationally. The company operates in two segments, Engineering and Other Scientific, and Environmental and Health. The Engineering and Other Scientific segment provides services in the areas of biomechanics, biomedical engineering and sciences, buildings and structures, civil engineering, construction consulting, data sciences, electrical engineering and computer science, human factors, materials and corrosion engineering, mechanical engineering, polymer science and materials chemistry, thermal sciences, and vehicle engineering.
See Also
- Five stocks we like better than Exponent
- What is a Low P/E Ratio and What Does it Tell Investors?
- Ignore the Noise—Samsara Stock Is Still a Strong Buy
- How to Short a Stock in 5 Easy Steps
- 3 Stocks Set to Double—And There’s Still Time to Buy
- TSX Venture Exchange (Formerly Canadian Venture Exchange)
- Analysts Can’t Get Enough of These Little-Known Biopharma Stocks
Want to see what other hedge funds are holding EXPO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Exponent, Inc. (NASDAQ:EXPO – Free Report).
Receive News & Ratings for Exponent Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Exponent and related companies with MarketBeat.com's FREE daily email newsletter.